The levels of p-STAT3 and p-STAT1 in GP130-deficient HEK293T cells were evaluated 48 h after transfection with pCMV6-GP130 (WT or mutant) or with an empty pCMV6 vector. After 15 min of stimulation with the various cytokines, cells were fixed with
fix buffer I (1:1 volume; BD Biosciences) for 10 min at 37 °C. Cells were then washed with FACS buffer (1X PBS + 2% FBS + 2 mM EDTA) and permeabilized by incubation for 20 min at 4 °C in
Perm buffer III (BD Biosciences). Finally, cells were stained by incubation for 1 h at 4 °C with
anti-STAT3-pY705 (antibody dilution 4:50; BD; 557815), or anti-STAT1-pY701 (antibody dilution 4:50; BD; 612597). Cells were analyzed on a
NovoCyte Flow cytometer (Agilent).
Arlabosse T., Materna M., Riccio O., Schnider C., Angelini F., Perreau M., Rochat I., Superti-Furga A., Campos-Xavier B., Héritier S., Pereira A., Deswarte C., Lévy R., Distefano M., Bustamante J., Roelens M., Borie R., Le Brun M., Crestani B., Casanova J.L., Puel A., Hofer M., Fieschi C., Theodoropoulou K., Béziat V, & Candotti F. (2023). New Dominant-Negative IL6ST Variants Expand the Immunological and Clinical Spectrum of GP130-Dependent Hyper-IgE Syndrome. Journal of Clinical Immunology, 43(7), 1566-1580.